SCHEMBL6524545

SCHEMBL6524545

O=c1ccc(-c2ccccn2)c(-c2ccccn2)[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.49
BTK Q06187 1/20 0.46
IDO1 P14902 1/20 0.46
LMNA P02545 5/20 0.45
KDM4E B2RXH2 5/20 0.45
HIF1A Q16665 2/20 0.45
METAP1 P53582 2/20 0.45
CCR1 P32246 2/20 0.45
CCR5 P51681 2/20 0.45
CCR8 P51685 2/20 0.45
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
BLM P54132 1/20 0.45
DOHH Q9BU89 1/20 0.45
P4HTM Q9NXG6 1/20 0.45
TGFBR1 P36897 1/20 0.42
CYP2A6 P11509 1/20 0.42
BRD4 O60885 1/20 0.41
PDE10A Q9Y233 1/20 0.41
NPC1 O15118 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5039401 0.88 TGFBR1 (0.54) CHEK1BTKIDO1LMNAKDM4E
SCHEMBL6679694 0.88 PDE10A (0.47) CHEK1BTKIDO1LMNAKDM4E
SCHEMBL11246077 0.81 CHEK1 (0.48) CHEK1BTKIDO1LMNAKDM4E
SCHEMBL6676566 0.81 BTK (0.49) CHEK1BTKIDO1LMNAKDM4E
SCHEMBL11097773 0.78 CHEK1 (0.46) CHEK1BTKIDO1LMNAKDM4E
SCHEMBL9989315 0.73 PDE3B (0.48) CHEK1BTKIDO1BRD4HTT
SCHEMBL404747 0.73 PRKCI (0.56) LMNAKDM4EHIF1AMETAP1CCR1
SCHEMBL6524542 0.72 IDO1 (0.50) CHEK1BTKIDO1LMNAKDM4E
SCHEMBL28264205 0.72 PRKCI (0.54) LMNAKDM4EHIF1AMETAP1CCR1
SCHEMBL11965541 0.71 KDM4E (0.68) LMNAKDM4EHIF1AMETAP1CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506186-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2005-02-16 EP claimed
WO-2003099808-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2003-12-04 WO claimed
EP-1506186-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2005-02-16 EP disclosed
EP-1465626-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING DIHYDROPYRIDINONE COMPOUNDS AND AN IMMUNOREGULATORY OR AN ANTIINFLAMMATORY AGENT AND THEIR USES Eisai Co., Ltd. (JP) 2004-10-13 EP disclosed
WO-2003099808-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2003-12-04 WO disclosed
WO-2003047577-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING DIHYDROPYRIDINONE COMPOUNDS AND AN IMMUNOREGULATORY OR AN ANTIINFLAMMATORY AGENT AND THEIR USES EISAI CO LTD (JP) 2003-06-12 WO disclosed